Nutex Health (NASDAQ:NUTX) Trading Down 4.7% - Here's Why

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s stock price traded down 4.7% on Wednesday . The stock traded as low as $108.01 and last traded at $108.44. 88,982 shares changed hands during trading, a decline of 6% from the average session volume of 94,736 shares. The stock had previously closed at $113.73.

Analysts Set New Price Targets

NUTX has been the subject of several recent research reports. Benchmark lifted their price objective on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a report on Thursday, May 15th. Maxim Group lifted their price target on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Finally, Wall Street Zen downgraded Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd.

Nutex Health Stock Performance

The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The stock has a market capitalization of $632.78 million, a PE ratio of 9.57 and a beta of -0.04. The business has a 50 day moving average price of $134.16 and a 200 day moving average price of $92.30.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $2.71. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%. The company had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million.

Institutional Trading of Nutex Health

Several institutional investors have recently made changes to their positions in the business. One Plus One Wealth Management LLC grew its holdings in Nutex Health by 3.3% during the 2nd quarter. One Plus One Wealth Management LLC now owns 38,791 shares of the company's stock valued at $4,829,000 after buying an additional 1,250 shares in the last quarter. Bank of America Corp DE grew its holdings in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. OMERS ADMINISTRATION Corp grew its holdings in Nutex Health by 28.8% during the 1st quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock valued at $442,000 after buying an additional 2,100 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Nutex Health by 17.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company's stock valued at $852,000 after buying an additional 2,748 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Nutex Health by 12.6% during the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock valued at $1,082,000 after buying an additional 3,826 shares in the last quarter. Hedge funds and other institutional investors own 5.32% of the company's stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.